氨基酸刺激的胰岛素分泌:在2型糖尿病中前进的道路
Jelena Kolic1, WenQing Grace Sun1, James D Johnson1
1Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, Canada.
Amino acids
|November 15, 2023
概括
氨基酸刺激胰岛素分泌,可能为2型糖尿病管理提供治疗方法. 需要进一步的研究来探索这种基于营养的治疗策略.
科学领域:
- 代谢研究的研究.
- 内分泌学 在内分泌学.
- 营养科学 营养科学
背景情况:
- 胰腺β细胞的胰岛素分泌对于血糖调节至关重要.
- 葡萄糖和非葡萄糖刺激,如氨基酸,都会触发胰岛素的释放.
- 了解氨基酸刺激的胰岛素分泌对于代谢健康至关重要.
研究的目的:
- 审查有关氨基酸刺激胰岛素分泌的现有文献.
- 确定当前研究中的共识领域和知识差距.
- 探索氨基酸在治疗2型糖尿病中的治疗潜力.
主要方法:
- 在体内 (口服和静脉注射) 和体外研究的综合文献综述.
- 对氨基酸和葡萄糖刺激胰岛素分泌现有数据的分析.
- 关于氨基酸在胰岛素释放中的作用的证据综合.
主要成果:
- 氨基酸刺激的胰岛素分泌与葡萄糖刺激的分泌相比,在2型糖尿病中显示相对保存.
- 有证据表明,氨基酸在胰岛素分泌中具有潜在的协同作用.
- 目前缺乏研究基于氨基酸的疗法的系统方法.
结论:
- 氨基酸代表了对2型糖尿病的有希望的治疗途径.
- 利用氨基酸刺激的胰岛素分泌可能会导致新的治疗方法.
- 建议进行进一步的研究,以开发基于营养的治疗方法,以缓解2型糖尿病.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Insulin Secretory Vesicles
5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
Glucagon-like Receptor Agonists
332
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
332
Hormones Regulating Blood Glucose
3.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.4K
Insulin: Biosynthesis, Chemistry, and Preparation
393
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
393
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K


